IRWD - IRONWOOD PHARMACEUTICALS INC

QQQ $ 446.25 $ -12.35 (-2.68 %)

DIA $ 404.28 $ -3.99 (-0.98 %)

SPY $ 539.90 $ -9.25 (-1.68 %)

TLT $ 99.49 $ -0.01 (-0.01 %)

GLD $ 230.65 $ -1.72 (-0.74 %)

Previous Close

$ 4.51

Open

Bid

$ 4.50 x 900

Ask

$ 4.51 x 1,400

Day's Range

-- - --

52 Week Range

$ 3.79 - $ 15.70

Volume

1,640,345

Average Volume

Market Cap

720.42M

Beta (5Y Monthly)

$ 0.42

PE Ratio (TTM)

$ 78.20

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-16-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-16-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-17-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-17-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	02-13-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	07-30-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	02-25-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-06-2018	06-30-2018	10-Q
26	05-04-2018	03-31-2018	10-Q
27	02-22-2018	12-31-2017	10-K
28	11-02-2017	09-30-2017	10-Q
29	08-03-2017	06-30-2017	10-Q
30	05-08-2017	03-31-2017	10-Q
31	02-22-2017	12-31-2016	10-K
32	11-07-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-10-2016	03-31-2016	10-Q
35	02-19-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-06-2015	03-31-2015	10-Q
39	02-18-2015	12-31-2014	10-K
40	11-05-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wells Fargo Maintains Overweight on Ironwo...
08/09/2024 22:30:45

Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight and lowers the price tar...

Craig-Hallum Maintains Buy on Ironwood Pha...
08/09/2024 16:17:19

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price ta...

Ironwood Has Revised Its FY 2024 Financial...
08/08/2024 11:08:13

Prior 2024 Guidance (May 9, 2024)Revised 2024 Guidance (August 8, 2024)U.S. LINZESS Net SalesMid-single digits % decline2Total ...

Ironwood Pharmaceuticals Q2 2024 Adj. EPS ...
08/08/2024 11:03:41

asana-clover-health-investments-hertz-global-and-other-big-stocks-moving-higher-on-friday

Asana, Clover Health Investments, Hertz Gl...
06/21/2024 14:45:13

Ironwood Pharmaceuticals Appoints Sravan K...
06/20/2024 20:13:46

- Form8

Ironwood Pharmaceuticals Will Present Late...
05/21/2024 10:13:47

New data highlight both stoma and colon-in-continuity (CIC) patients drove the positive primary endpoint with significant rel...

Craig-Hallum Maintains Buy on Ironwood Pha...
05/10/2024 16:26:45

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price ta...

why-duolingo-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Duolingo Shares Are Trading Lower By A...
05/09/2024 17:57:05

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

Ironwood Pharmaceuticals Lowers 2024 Guida...
05/09/2024 11:31:10

Ironwood 2024 Financial Guidance. Ironwood has revised its FY 2024 financial guidance due to a LINZESS gross-to-net change in...

Ironwood Pharmaceuticals Q1 2024 Adj EPS $...
05/09/2024 11:14:05

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.02) per share which missed the analyst consensus estima...

$ironwood-pharmaceuticals-announces-results-from-phase-2-exploratory-stargaze-trial-of-apraglutide-for-steroid-refractory-gastrointestinal-acute-graft-versus-host-disease$

Ironwood Pharmaceuticals Announces Results...
03/28/2024 11:33:10

First prospective trial of a glucagon-like peptide (GLP-2) analog in SR GI aGVHD. Results up to Day 91 show that apraglutide...

top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-march

Top 3 Health Care Stocks That Could Lead T...
03/07/2024 12:18:46

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Wells Fargo Maintains Overweight on Ironwo...
03/01/2024 18:00:24

Wells Fargo analyst Mohit Bansal maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight and lowers the price tar...

why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Butterfly Network Shares Are Trading L...
02/29/2024 19:00:01

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
02/29/2024 17:32:04

why-is-gastrointestinal-healthcare-focused-ironwood-pharmaceuticals-stock-sinking-on-thursday

Why Is Gastrointestinal Healthcare Focused...
02/29/2024 16:34:52

Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by...

Nasdaq Gains 100 Points Following PCE Data
02/29/2024 15:40:00

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the ...

tech-stocks-set-to-rise-thursday-as-january-inflation-data-fails-to-scare-markets-small-caps-surge

Tech Stocks Set To Rise Thursday As Januar...
02/29/2024 14:20:35

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 5...